Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of AL-12182 in Glaucoma and Ocular Hypertension
NCT00069719Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Feb 1999
- Primary completion
- Aug 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of AL-12182 in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Feb 1999; status: completed.
02
Drugs
AL-12182
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00069719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00069719.